\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes ERCThe final report and associated repository inventory represent the output of a study conducted between March and October 2022 by a group of independent experts and commissioned by the European Research Council Executive Agency (ERCEA). In this study the experts assess and analyse the readiness of research data and literature repositories to facilitate compliance with the Open Science requirements in the Horizon Europe Model Grant Agreement (HE MGA 2022). This study also takes current repository choice practices of ERC-funded researchers into account. The final report, the inventory of identified trusted repositories and questionnaire used to survey repository managers are publicly available on Zenodo. Conclusions are summarised in this ERC news article.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
